TNFRSF9 and leukemia: In this review I will focus on how to exploit the inhibitory activity of tumor necrosis factor (TNF) receptors, 4-1BB and glucocorticoid-induced TNFR-related (GITR) in NK anti-leukemia activity to improve therapeutic NK cell intervention.